[1]
B. . T. Alany and M. AbdulSahib, “Tocilizumab and IL-6 Signaling in Rheumatoid Arthritis: Clinical Implications for Infection Detection and CRP Limitations (Narrative Review with a Retrospective Case Series)”, jpdd, vol. 4, no. 1, pp. 49–60, Jun. 2026, Accessed: Jun. 03, 2026. [Online]. Available: https://jpdd.nahrainuniv.edu.iq/jpdd/article/view/31